EBS vs UBER · rev $1.04B vs P/E 18, rev $52.02B
Emergent Biosolutions Inc (EBS) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
EBS currently screens at market cap $416.4M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the EBS and UBER stock pages for the full models.
Not investment advice.